Trial Profile
A prospective, randomized, multicenter, clinical study to evaluate the efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Pirarubicin (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 27 Nov 2015 New trial record